Purple Biotech Reports First Quarter 2024 Financial Results
May 21, 2024 07:30 ET
|
Purple Biotech Ltd.
REHOVOT, Israel, May 21, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that...
Jayud Announces New Certification and Launch of Longgang E-Commerce Operation Center
May 21, 2024 07:30 ET
|
Jayud Global Logistics Ltd
Hosted Event with Local Government Officials, Taxation Bureau, and Customs Officials to Educate and Promote the Center SHENZHEN, China, May 21, 2024 (GLOBE NEWSWIRE) -- Jayud Global...
Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease
May 21, 2024 07:30 ET
|
Cognition Therapeutics, Inc.
PURCHASE, N.Y., May 21, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative...
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
May 21, 2024 07:15 ET
|
SAB Biotherapeutics, Inc.
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®
May 21, 2024 07:05 ET
|
Clearside Biomedical, Inc.
- Expert Panel of Ophthalmologists Developed Professional Guidelines in Using the Innovative Technique for Retinal Therapeutic Delivery - - Current Clinical Evidence and Physician Experience Support...
BlackLine, Inc. Announces Proposed Private Offering of $500,000,000 of Convertible Senior Notes
May 21, 2024 07:00 ET
|
BlackLine, Inc.
LOS ANGELES, May 21, 2024 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL), today announced that it intends to offer, subject to market conditions and other factors, $500,000,000 aggregate principal...
Orgenesis Provides Business Update for the First Quarter of 2024
May 21, 2024 07:00 ET
|
Orgenesis Inc.
GERMANTOWN, Md., May 21, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene...
ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International Conference
May 21, 2024 07:00 ET
|
ASLAN PHARMACEUTICALS LIMITED
Translational data presented during a late-breaker poster session from a head-to-head study of eblasakimab and dupilumab in a human tissue model of COPD indicates that eblasakimab performed better...
Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therapeutic Potential of MRT-6160 in Inflammatory Bowel Disease
May 21, 2024 07:00 ET
|
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therapeutic Potential of MRT-6160
ECARX-Powered Lynk & Co. 07 EM-P Sedan Began Deliveries in China
May 21, 2024 07:00 ET
|
ECARX LIMITED
SHANGHAI, China, May 21, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology company, today congratulated Lynk & Co on the first...